Skip to main content
. 2022 Mar 19;23:62. doi: 10.1186/s12931-022-01976-0

Table 1.

Baseline characteristics of patients with IPF

Value
Number of patients with IPF 1737
Total follow-up period (patient-years) 3720
Median follow-up in years (IQR) 2.0 (0.9–3.2)
Sociodemographic characteristics at index date
 Male sex, n (%) 1173 (67.5)
 Age at index date (years), mean (SD) 72.1 (10.4)
Insurance status at index date, n (%)
 Retired 1489 (85.7)
 Employed 143 (8.2)
 Unemployed 51 (2.9)
 Voluntarily insured 37 (2.1)
 Family-insured 17 (1.0)
Comorbidities in baseline period
 CCI score at index date, median (IQR) 4.0 (2.0–6.0)
 Lung cancer, n (%) 106 (6.1)
 COPD, n (%) 691 (39.8)
 Asthma, n (%) 282 (16.2)
 Heart failure, n (%) 622 (35.8)
 Arterial hypertension, n (%) 1411 (81.2)
 Type 2 diabetes mellitus, n (%) 647 (37.2)
 GERD, n (%) 418 (24.1)
 Chronic ischemic heart disease, n (%) 667 (38.4)
 Dyslipidemia, n (%) 889 (51.2)
Outpatient visits, hospitalizations, and procedures in baseline period
 Number of GP visits per patient, mean (SD) 4.6 (1.8)
 Number of pulmonologist visits per patient, mean (SD) 0.9 (1.2)
 Number of other specialist visits per patient, mean (SD) 10.1 (6.2)
 Number of all-cause hospitalizations per patient, mean (SD) 1.1 (1.8)
 Number of days spent in hospital per patient, mean (SD) 8.2 (18.5)
 Lung transplant, n (%) 7 (0.4)
Top five prescribed drug classes in baseline period, n (%)
 Proton pump inhibitors 787 (45.3)
 Beta blocking agents, selective 774 (44.6)
 Statins 641 (36.9)
 Sulfonamide-diuretics, plain 590 (34.0)
 Pyrazalones 518 (29.8)
Top five inpatient main diagnoses in baseline period, n (%)
 Pneumonia 102 (5.9)
 Heart failure 90 (5.2)
 COPD 65 (3.7)
 Neoplasm of uncertain behavior of middle ear and respiratory and intrathoracic organs 41 (2.4)
 Chronic ischemic heart disease 36 (2.1)

The respective baseline period is 12 months prior to the index date. “Retired” includes pension applicants; For the respective ATC, OPS, and ICD-10-GM codes, see Additional file 1: Table S3

ATC Anatomical Therapeutic Chemical, CCI Charlson Comorbidity Index, COPD chronic obstructive pulmonary disease, GERD gastroesophageal reflux disease, GP general practitioner, ICD-10-GM German Modification of the International Classification of Diseases, IPF idiopathic pulmonary fibrosis, IQR interquartile range, OPS Operationen-und Prozedurenschlüssel/operation and procedure classification, SD standard deviation